Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Franklin

Showing results (211-220 of 417) with videos related to

Pageof 42
Sort By:
Kidney International|May 1, 1975
Control of aldosterone responsiveness in terminal renal failureP Weidmann, M H Maxwell, J De Lima, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 28, 2017
Detection of ASC Speck Formation by Flow Cytometry and Chemical Cross-linkingFlorian Hoss, Verena Rolfes, Mariana R Davanso, et al.
Journal of Visualized Experiments : Jove|June 2, 2017
Expression, Purification, and Antimicrobial Activity of S100A12Emmanuel Jackson, Saffron Little, Dana S Franklin, et al.
Open Forum Infectious Diseases|March 4, 2015
Learning Data-Driven Patient Risk Stratification Models for Clostridium difficileJenna Wiens, Wayne N Campbell, Ella S Franklin, et al.
British Medical Journal|May 1, 1976
Four new anti-inflammatory drugs: responses and variationsE C Huskisson, D L Woolf, H W Balme, et al.
Hypertension (Dallas, Tex. : 1979)|September 18, 2013
White-coat hypertension: new insights from recent studiesStanley S Franklin, Lutgarde Thijs, Tine W Hansen, et al.
Hypertension (Dallas, Tex. : 1979)|December 26, 2001
Pressure amplification explains why pulse pressure is unrelated to risk in young subjectsI B Wilkinson, S S Franklin, I R Hall, et al.
Circulation|July 27, 1999
Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart studyS S Franklin, S A Khan, N D Wong, et al.
European Journal of Pharmacology|December 12, 1995
The effect of the irreversible mu-opioid receptor antagonist clocinnamox on morphine potency, receptor binding and receptor mRNAK Chan, M Brodsky, T Davis, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|December 16, 2006
Efficacy and safety of irbesartan/HCTZ combination therapy as initial treatment for rapid control of severe hypertensionJoel M Neutel, Stanley S Franklin, Suzanne Oparil, et al.
Pageof 42

Showing results (211-220 of 417) with videos related to

Sort By:
Pageof 42
Kidney International|May 1, 1975
Control of aldosterone responsiveness in terminal renal failureP Weidmann, M H Maxwell, J De Lima, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 28, 2017
Detection of ASC Speck Formation by Flow Cytometry and Chemical Cross-linkingFlorian Hoss, Verena Rolfes, Mariana R Davanso, et al.
Journal of Visualized Experiments : Jove|June 2, 2017
Expression, Purification, and Antimicrobial Activity of S100A12Emmanuel Jackson, Saffron Little, Dana S Franklin, et al.
Open Forum Infectious Diseases|March 4, 2015
Learning Data-Driven Patient Risk Stratification Models for Clostridium difficileJenna Wiens, Wayne N Campbell, Ella S Franklin, et al.
British Medical Journal|May 1, 1976
Four new anti-inflammatory drugs: responses and variationsE C Huskisson, D L Woolf, H W Balme, et al.
Hypertension (Dallas, Tex. : 1979)|September 18, 2013
White-coat hypertension: new insights from recent studiesStanley S Franklin, Lutgarde Thijs, Tine W Hansen, et al.
Hypertension (Dallas, Tex. : 1979)|December 26, 2001
Pressure amplification explains why pulse pressure is unrelated to risk in young subjectsI B Wilkinson, S S Franklin, I R Hall, et al.
Circulation|July 27, 1999
Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart studyS S Franklin, S A Khan, N D Wong, et al.
European Journal of Pharmacology|December 12, 1995
The effect of the irreversible mu-opioid receptor antagonist clocinnamox on morphine potency, receptor binding and receptor mRNAK Chan, M Brodsky, T Davis, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|December 16, 2006
Efficacy and safety of irbesartan/HCTZ combination therapy as initial treatment for rapid control of severe hypertensionJoel M Neutel, Stanley S Franklin, Suzanne Oparil, et al.
Pageof 42